1950
DOI: 10.1093/oxfordjournals.jhered.a106105
|View full text |Cite
|
Sign up to set email alerts
|

A New Mutation With Asymmetrical Expression in the Mouse

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
14
0

Year Published

1958
1958
2013
2013

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 43 publications
(14 citation statements)
references
References 0 publications
0
14
0
Order By: Relevance
“…Because of the higher degree of binding in the two-hybrid assay between L9 and MMTV(C3H) Gag compared to MMT-V(HP/Mtv1), we tested whether L9 overexpression would change the localization of Gag derived from Mtv1. In fact, L9 overexpression also induced localization of a subpopulation of Mtv1 Gag to nucleoli (data not shown), indicating that the difference in binding affinity observed in the quantitative yeast two-hybrid assay was not apparent in NMuMG cells, which are derived from Namru mice (37)(38)(39). It is possible that Namru mice, like BALB/cJ mice, do not exhibit differences in the rates of tumor formation with variants of MMTV tested by Swanson et al (34) (Fig.…”
Section: Resultsmentioning
confidence: 79%
“…Because of the higher degree of binding in the two-hybrid assay between L9 and MMTV(C3H) Gag compared to MMT-V(HP/Mtv1), we tested whether L9 overexpression would change the localization of Gag derived from Mtv1. In fact, L9 overexpression also induced localization of a subpopulation of Mtv1 Gag to nucleoli (data not shown), indicating that the difference in binding affinity observed in the quantitative yeast two-hybrid assay was not apparent in NMuMG cells, which are derived from Namru mice (37)(38)(39). It is possible that Namru mice, like BALB/cJ mice, do not exhibit differences in the rates of tumor formation with variants of MMTV tested by Swanson et al (34) (Fig.…”
Section: Resultsmentioning
confidence: 79%
“…Formalin-killed spherule vaccines from C. immitis strain Silveira were prepared and purified as described previously (14). A total dose of 2.0 to 2.4 mg was given intramuscularly in 3 or 4 weekly injections (0.1 ml) to female albino mice of the Namru strain (6), beginning at 5 to 7 weeks of age (18 to 21 g). In one case, pulverized spherules (Savage, Ph.D. Thesis, Univ.…”
Section: Methodsmentioning
confidence: 99%
“…Albino female mice (Namru strain; Garber & Hauth, 1950) were given the first of 3 or 4 injections of vaccine (0.1 or 0.2 ml.) at 6 to 9 weeks of age (18 to 25 g.) either intramuscularly (i.m.)…”
Section: Vaccination and Challengementioning
confidence: 99%